Immunotherapy treatment shows promise for some patients with advanced rare cancers

Immunotherapy treatment shows promise for some patients with advanced rare cancers

Immunotherapy treatment shows promise for some patients with advanced rare cancers

A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity in patients with four types of advanced, hard-to-treat rare cancers.